Pretargeting for cancer radioimmunotherapy with bispecific antibodies: Role of the bispecific antibody's valency for the tumor target antigen

Bioconjugate Chemistry

Volumn 13, Issue 5, 2002, Pages 1054-1070

  Karacay, H ^a   Sharkey, R M ^a   McBride, W J ^b   Griffiths, G L ^b   Qu, Z ^b   Chang, K ^c   Hansen, H J ^b   Goldenberg, D M ^a  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

^b IMMUNOMEDICS INC   (United States)

^c IBC Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ANTIGENS; BLOOD; CELL MEMBRANES; MOLECULAR WEIGHT; PEPTIDES;

BLOCKING AGENTS; BOVINE SERUM ALBUMINS; CARCINOEMBRYONIC ANTIGEN; CELL SURFACES; CROSS LINKING; DIVALENTS; RADIOIMMUNOTHERAPY; TUMOR TARGETS; TUMOR UPTAKE; VALENCIES;

TUMORS;

BOVINAE;

BISPECIFIC ANTIBODY; BLOCKING ANTIBODY; CANCER ANTIBODY; CARCINOEMBRYONIC ANTIGEN; HAPTEN; TECHNETIUM; TUMOR ANTIGEN;

ANIMAL; ANTIBODY AFFINITY; ARTICLE; CHEMISTRY; EXPERIMENTAL NEOPLASM; HUMAN; IMMUNOLOGY; METHODOLOGY; MOUSE; RADIOIMMUNOTHERAPY; TISSUE DISTRIBUTION; XENOGRAFT;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODIES, BLOCKING; ANTIBODIES, NEOPLASM; ANTIBODY AFFINITY; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; HAPTENS; HUMANS; MICE; NEOPLASMS, EXPERIMENTAL; RADIOIMMUNOTHERAPY; TECHNETIUM; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036738622     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0200172     Document Type: Article

References (49)

1. 90Y radioimmunotherapy in a mouse xenograft model. J. Immunother. 16, 158.
2. Axworthy, D. B., Reno, J. M., Hylarides, M. D., Mallett, R. W., Theodore, L. J., Gustavson, L. M., Su, F., Hobson, L. J., Beaumier, P. L., and Fritzberg, A. R. (2000) Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. Proc. Natl. Acad. Sci. U.S.A. 97, 1802-1807.
3. Barbet, J., Peltier, P., Bardet, S., Vuillez, J. P., Bachelot, I., Denet, S., Olivier, P., Leccia, F., Corcuff, B., Huglo, D., Proye, C., Rouvier, E., Meyer, P., and Chatal, J.-F. (1998) Radioimunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. J. Nucl. Med. 39, 1172-1178.
4. Boerman, O. C., Kranenborg, M. H. G. C., Oosterwijk, E., Griffiths, G. L., McBride, W. J., Oyen, W. J., de Weijert, M., Oosterwijk, J., Hansen, H. J., and Corstens, F. H. M. (1999) Pretargeting of renal cell carcinoma: Improved tumor targeting with a bivalent chelate. Cancer Res. 59, 4400-4405.
5. Bos, E. S., Kuijpers, W. H., Meesters-Winters, M., Pharm, D. T., de Haan, A. S., van Doornmalen, A. M., Kaspersen, F. M., van Boeckel, C. A., and Gougeon-Betrand, F. (1994) In vitro evaluation of DNA-DNA hybridization as a two-step approach in radioimmunotherapy of cancer. Cancer Res. 54, 3479-3486.
6. 90Y-DOTA-biotin with pertargeted NR-LU-10/streptavidin. Cancer Biother. Radiopharm. 14, 381-395.
7. Breitz, H. B., Weiden, P. L., Beaumier, P. L., Axworthy, D. B., Seiler, C., Su, F. M., Graves, S., Bryan, K., and Reno, J. M. (2000) Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin. J. Nucl. Med. 41, 131-140.
8. Chang, C.-H., Sharkey, R. M., Rossi, E. A., Karacay, H., McBride, W., Hansen, H. J., Chatal, J.-F., Barbet, J., and Goldenberg, D. M. (2002) Molecular advances in pretargeting radioimmunotherapy with bispecific antibodies. Mol. Cancer Ther. 1, 553-563.
9. Cremonesi, M., Ferrari, M., Chinol, M., Stabin, M. G., Grana, C., Prisco, G., Robertson, C., Tosi, G., and Paganelli, G. (1999) Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients. Eur. J. Nucl. Med. 26, 110-120.
10. Gautherot, E., Le Doussal, J.-M., Bouhou, J., Manetti, C., Martin, M., Rouvier, E., and Barbet, J. (1998) Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens. J. Nucl. Med. 39, 1937-1943.
11. 131I-labeled bivalent hapten. J. Nucl. Med. 41, 480-487.
12. Goldenberg, D. M. (2002) Targeted therapy of cancer with radiolabeled antibodies. J. Nucl. Med. 43, 693-713.
13. Goldenberg, D. M., and Hansen, H. J. (1972) Carcinoembryonic antigen present in human colonic neopasms serially propagated in hamsters. Science 175, 1117-1118.
14. Goldenberg, D. M., Witte, S., and Elster, K. (1966) GW-39: A new human tumor serially transplantable in the golden hamster. Transplantation 4, 760-763.
15. Goodwin, D. A., and Meares, C. F. (1999) Pretargeted peptide imaging and therapy. Cancer Biother. Radiopharm. 14, 145-152.
16. Goodwin, D. A., Meares, C. F., McCall, M. J., McTigue, M., and Chaovapong, W. (1988) Pre-targeted immunoscintigraphy of murine tumor with indium-111-labeled bifunctional haptens. J. Nucl. Med. 29, 226-234.
17. Goodwin, D. A., Meares, C. F., McTigue, M., Chaovapong, W., Diamanti, C. I., Ransone, C. H., and McCall, M. J. (1992) Pretargeted immunoscintigraphy: Effect of hapten valency on murine tumor uptake. J. Nucl. Med. 33, 2006-2013.
18. Greenwood, F. C., and Hunter, W. M. (1963) The preparation of I-131 labeled human growth hormone of high specific radioactivity. Biochem. J. 89, 114-123.
19. Hnatowich, D. J., Layne, W. W., and Childs, R. L. (1982) The preparation and labeling of DTPA-coupled albumin. Int. J. Appl. Radiat. Isot. 33, 327-332.
20. Hnatowich, D. J., Virzi, F., and Rusckowski, M. (1987) Investigations of avidin and biotin for imaging applications. J. Nucl. Med. 28, 1294-1302.
21. Karacay, H., Sharkey, R. M., Griffiths, G. L., Govindan, S. V., McBride, W. J., Goldenberg, D. M., and Hansen, H. J. (1997) Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer: Reagent development. Bioconjugate Chem. 8, 585-594.
22. 188Re-labeled peptide. Bioconjugate Chem. 11, 842-854.
23. v6/anti-gallium chelate antibodies. J. Nucl. Med. 39, 1769-1776.
24. Knox, S. J., Goris, M. L., Tempero, M., Weiden, P. L., Gentner, L., Breitz, H., Adams, G. P., Axworthy, D., Gaffigan, S., Bryan, K., Fisher, D. R., Colcher, D., Horak, I. D., and Weiner, L. M. (2000) Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. Clin. Cancer Res. 6, 406-414.
25. Kraeber-Bodéré, F., Faivre-Chauvet, A., Saï-Maurel, C., Gautherot, E., Fiche, M., Campion, L., Le Boterff, J., Barbet, J., Chatal, J.-F., and Thédrez, P. (1999) Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft. J. Nucl. Med. 40, 198-204.
26. Le Doussal, J.-M., Martin, M., Gautherot, E., Delaage, M., and Barbet, J. (1989) In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: Enhanced divalent hapten affinity for cell bound antibody conjugates. J. Nucl. Med. 30, 1358-1366.
27. Le Doussal, J.-M., Gruaz-Guyon, A., Martin, M., Gautherot, E., Delaage, M., and Barbet, J. (1990) Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: Imaging of tumors hosted in nude mice. Cancer Res. 50, 3445-3452.
28. Le Doussal, J.-M., Chetanneau, A., Gruaz-Guyon, A., Martin, M., Gautherot, E., Lehur, P.-A., Chatal, J.-F., Delaage, M., and Barbet, J. (1993) Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: Pharmacokinetics, biodistribution, scintigraphy and immune response. J. Nucl. Med. 34, 1662-1671.
29. Lee, Y.-C., Atowell, C. P., and Krantz, M. J. (1976) 2-Imino-2-methoxyethyl-1-thioglycosides: New reagents for attaching sugars to proteins. Biochemistry 15, 3956-3963.
30. Leung, S. O., Shevitz, J., Pellegrini, M. C., Dion, A. S., Shih, L. B., Goldenberg, D. M., and Hansen, H. J. (1994) Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma. Hybridoma 13, 469-476.
31. Leung, S. O., Goldenberg, D. M., Dion, A. S., Pellegrini, M. C., Shevitz, J., Shih, L. B., and Hansen, H. J. (1995) Construction and characterization of a humanized, internalizing, B-cell (CD22)-specific, leukemia/lymphoma antibody, LL2. Mol. Immunol. 32, 1413-1427.
32. Losman, M. J., Novick, K. E., Goldenberg, D. M., and Monestier, M. (1994) Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti-idiotype antibody. Int. J. Cancer 56, 580-584.
33. Lubic, S. P., Goodwin, D. A., Meares, C. F., Song, C., Osen, M., and Hays, M. (2001) Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma. J. Nucl. Med. 42, 670-678.
34. Magnani, P., Fazio, F., Grana, C., Songini, C., Frigerio, L., Pecorelli, S., Mangili, G., Colombo, N., Mariani, C. D., and Paganelli, G. (2000) Diagnosis of persistent ovarian carcinoma with three-step immunoscintigraphy. Br. J. Cancer 82, 616-620.
35. Mattes, M. J. (1987) Biodistribution of antibodies after intraperitoneal or intravenous injection and the effect of carbohydrate modification. J. Natl. Cancer Inst. 79, 855-863.
36. Meares, C. F., McCall, M. J., Reardon, D. T., Goodwin, D. A., Diamanti, C. I., and McTigue, M. (1984) Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Anal. Biochem. 142, 68-78.
37. Paganelli, G., Riva, P., Deleide, G., Clivio, A., Chiolerio, F., Scassellati, G. A., Malcovati, M., and Siccardi, A. G. (1988) In vivo labeling of biotinylated monoclonal antibodies by radioactive avidin: a strategy to increase tumor radiolocalization. Int. J. Cancer Suppl. 2, 121-125.
38. 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results. Cancer Biother. Radiopharm. 16, 227-235.
39. Penefsky, H. S. (1979) A centrifuged column procedure for the measurement of ligand binding by beef heart F1. Part G. Methods Enzymol. 56, 527-530.
40. Reardan, D. T., Meares, C. F., Goodwin, D. A., McTigue, M., David, G. S., Stone, M. R., Leung, J. P., Bartholomew, R. M., and Frincke, J. M. (1985) Antibodies to metal chelates. Nature 316, 265-268.
41. Rosebrough, S. F., and Hartley, D. F. (1995) Quantification and lowering of serum biotin. Lab Anim. Sci. 45, 554-557.
42. Rusckowski, M., Qu, T., Chang, F., and Hnatowich, D. J. (1997a) Pretargeting using peptide nucleic acid. Cancer (Suppl.) 80, 2699-2705.
43. Rusckowski, M., Fogarasi, M., Fritz, B., and Hnatowich D. J. (1997b) Effect of endogenous biotin on the application of streptavidin and biotin in mice. Nucl. Med. Biol. 24, 263-268.
44. Schuhmacher, J., Kaul, S., Klivenyi, G., Junkermann, H., Magener, A., Henze, M., Doll, J., Haberkorn, U., Amelung, F., and Bastert, G. (2001) Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies. Cancer Res. 61, 3712-3717.
45. Sharkey, R. M., Juweid, M., Shevitz, J., Behr, T., Dunn, R., Swayne, L. C., Wong, G. Y., Blumenthal, R. D., Griffiths, G. L., Siegel, J. A., Leung, S., Hansen, H. J., and Goldenberg, D. M. (1995) Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies. Cancer Res. 55, 5935s-5945s.
46. Sharkey, R. M., Karacay, H., Griffiths, G. L., Behr, T. M., Blumenthal, R. D., Mattes, M. J., Hansen, H. J., and Goldenberg, D. M. (1997) Development of a streptavidin-anticarcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model. Bioconjugate Chem. 8, 595-604.
47. Sharkey, R. M., Rossi, E., Karacay, H., McBride, W., Chang, K., Zang, L., Qu, T., Griffiths, G. L., Hansen, H. J., and Goldenberg, D. M. (2001) A novel, recombinant, bispecific antibody pretargeting system for cancer radioimmunotherapy. Clin. Cancer Res. (Suppl.) 7, 3786s.
48. Stickney, D. R., Anderson, L. D., Slater, J. B., Ahlem, C. N., Kirk, G. A., Schweighardt, S. A., and Frincke, J. M. (1991) Bifunctional antibody: A binary radiopharmaceutical delivery system for imaging colorectal carcinoma. Cancer Res. 51, 6650-6655.
49. Vuillez, J.-P., Kraeber-Bodéré, F., Moro, D., Bardiès, M., Douillard, J.-Y., Gautherot, E., Rouvier, E., Barbet, J., Garban, F., Moreau, P., and Chatal, J.-F. (1999) Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/antidiethylenetriaminepentacetic acid (DTPA) antibody and iodine-131 di-DTPA hapten: Results of a phase I/II trial. Clin. Cancer Res. (Suppl.) 5, 3259s-3267s.